Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherta, Mahabubager-509 301, India, NDC 31722-713-10
Published April 29, 2026 · Recall initiated: March 26, 2026
Summary
FDA records drug Class II recall D-0484-2026, published April 29, 2026 and initiated March 26, 2026. Recalling firm: Hetero Labs Limited (Unit V); Status: Ongoing; Reported quantity: 4,740 1,000-count bottles.; Lot: Batch # FD253967, Exp Date: 06/26/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."
What to do
Voluntary: Firm initiated
Get an email if PANTOPRAZOLE SODIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PANTOPRAZOLE SODIUM
- Manufacturer
- Hetero Labs Limited (Unit V)
- Distributor
- Nationwide in the USA.
- UPC
- 0331722713900
- Lot
- Batch # FD253967, Exp Date: 06/26/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAPantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) Single-Dose Infusion Bag inSeptember 9, 2026
- FDAFurosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield,April 29, 2026
- FDAGentuity HF-OCT Imaging System Model G10-01; Software version 23.2.13;April 22, 2026
- FDAPantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged as (a) 10September 20, 2023
- FDAPantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: CamberApril 19, 2023
- FDAPantoprazole Sodium for Delayed-Release Oral Suspension*40 mg* suspension in apple juice or applesauce onlyNovember 30, 2022
Questions about this recall
Was Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherta, Mahabubager-509 301, India, NDC 31722-713-10 recalled?
Yes. FDA published recall D-0484-2026 on April 29, 2026. Reported hazard: Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PANTOPRAZOLE SODIUM. UPC: 0331722713900.